Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Atoltivimab/maftivimab/odesivimab: History & Applications

Atoltivimab/maftivimab/odesivimab, sold under the brand name INMAZEB, is a fixed-dose combination of three monoclonal antibodies for the treatment of ebola caused by Zaire ebolavirus. It was developed by Regeneron Pharmaceuticals and contains three human monoclonal antibodies, atoltivimab, maftivimab, and odesivimab-ebgn.

Language: English [EN]
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
100%
More settings
100% 100% 100% 100% 100%

Atoltivimab/maftivimab/odesivimab topic overview

The analysis highlights History and Applications as prominent areas in the source structure around Atoltivimab/maftivimab/odesivimab.

Related topics
32
Source areas
4
Connected nodes
36
Extracted relationships
45
Related term clusters
18
Bridge connections
36

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

History · 16 topics
Overview · 13 topics
Pharmacology · 2 topics
Medical uses · 1 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

AHFS/Drugs.com
Monograph
ATC code
None
Atoltivimab
Monoclonal antibody
CAS Number
2500649-90-9
KEGG
D11922
Legal status
US: ℞-only

Start with your topic. Discover where to go next.

Explore different angles and find fresh ideas to shape your next piece of content.

Atoltivimab/maftivimab/odesivimab
8Fixed-dose combination · Monoclonal antibodies · Ebola
24Tachycardia · Tachypnea · Food and Drug Administration

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Medical uses

Pharmacology

History

For the semantics nerds

You can skip this section if you’re here for content ideas and keyword inspiration.

Advanced semantic analysis

How Atoltivimab/maftivimab/odesivimab connects Entity context

The extracted context around Atoltivimab/maftivimab/odesivimab shows recurring relationship patterns in the source. For example, Atoltivimab/maftivimab/odesivimab → Approximately, Congo, Democratic Republic, Despite, DRC, Ebola, In November, Kivu, Kivu Ebola, Ministry, PALM, Pamoja Tulinde Maisha, Public Health, REGN-EB3, Together Save Lives, WHO MEURI, World Health Organization MEURI, ZMapp Another extracted example is Atoltivimab/maftivimab/odesivimab → European Medicines Agency, INMAZEB, October, Regeneron Pharmaceuticals, REGN-EB3, The FDA, Zaire. Use these groups to spot repeated connection types before inspecting the individual relationships.

Atoltivimab/maftivimab/odesivimab

Top relations

related to PALM trial · 18
Atoltivimab/maftivimab/odesivimab → Approximately, Congo, Democratic Republic, Despite, DRC, Ebola, In November, Kivu, Kivu Ebola, Ministry, PALM, Pamoja Tulinde Maisha, Public Health, REGN-EB3, Together Save Lives, WHO MEURI, World Health Organization MEURI, ZMapp
related to Regulatory status · 7
Atoltivimab/maftivimab/odesivimab → European Medicines Agency, INMAZEB, October, Regeneron Pharmaceuticals, REGN-EB3, The FDA, Zaire
related to Mechanism of action · 4
Atoltivimab/maftivimab/odesivimab → Bundibugyo, Ebola, The Sudan, Zaire
related to Contraindications · 2
Atoltivimab/maftivimab/odesivimab → Ebola, People
AHFS/Drugs.com · 1
Atoltivimab/maftivimab/odesivimab → Monograph
ATC code · 1
Atoltivimab/maftivimab/odesivimab → None
Atoltivimab · 1
Atoltivimab/maftivimab/odesivimab → Monoclonal antibody
CAS Number · 1
Atoltivimab/maftivimab/odesivimab → 2500649-90-9
KEGG · 1
Atoltivimab/maftivimab/odesivimab → D11922
Legal status · 1
Atoltivimab/maftivimab/odesivimab → US: ℞-only

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

atoltivimab maftivimab mab114 ebola regn-eb3 odesivimab trial treatment virus zaire monoclonal outbreak infection drug ebolavirus patients participants antibodies zmapp drc

Atoltivimab/maftivimab/odesivimab relationships Subject–Predicate–Object triples

TTTA extracted 45 structured relationships around Atoltivimab/maftivimab/odesivimab. Examples in this analysis include Atoltivimab/maftivimab/odesivimab → AHFS/Drugs.com → Monograph and Atoltivimab/maftivimab/odesivimab → ATC code → None. The table shows each extracted connection, where it came from and its confidence.

SubjectPredicateObjectConfidenceSrc
Atoltivimab/maftivimab/odesivimabAHFS/Drugs.comMonograph1.00infobox
Atoltivimab/maftivimab/odesivimabATC codeNone1.00infobox
Atoltivimab/maftivimab/odesivimabAtoltivimabMonoclonal antibody1.00infobox
Atoltivimab/maftivimab/odesivimabCAS Number2500649-90-91.00infobox
Atoltivimab/maftivimab/odesivimabKEGGD119221.00infobox
Atoltivimab/maftivimab/odesivimabLegal statusUS: ℞-only1.00infobox
Atoltivimab/maftivimab/odesivimabLicense dataUS DailyMed: Inmazeb1.00infobox
Atoltivimab/maftivimab/odesivimabMaftivimabMonoclonal antibody1.00infobox
Atoltivimab/maftivimab/odesivimabOdesivimabMonoclonal antibody1.00infobox
Atoltivimab/maftivimab/odesivimabOther namesREGN-EB31.00infobox
Atoltivimab/maftivimab/odesivimabRoutes of administrationIntravenous1.00infobox
Atoltivimab/maftivimab/odesivimabTrade namesInmazeb1.00infobox
Atoltivimab/maftivimab/odesivimabis afirst FDA-approved treatment for Zaire ebolavirus0.90text

Related concept clusters Related term clusters

The concept neighborhoods around Atoltivimab/maftivimab/odesivimab bring nearby vocabulary together. In this analysis, examples include Maftivimab, Odesivimab and Ebolavirus. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

  • Atoltivimab/maftivimab/odesivimab
    • Maftivimab
    • Odesivimab
    • Ebolavirus
    • Monoclonal
    • Zaire
    • Treatment
    • Antibodies
    • Administration
    • Combination
    • Inmazeb
    • Caused
    • Three
  • atoltivimab/maftivimab/odesivimab
    • Maftivimab
    • Odesivimab
    • Ebolavirus
    • Monoclonal
    • Zaire
    • Treatment
    • Antibodies
    • Administration
    • Combination
    • Inmazeb
    • Caused
    • Palm
  • monoclonal antibodies
    • Three
    • Antibody
    • Monoclonal
    • Combination
    • Zaire
    • Atoltivimab
    • Maftivimab
    • Odesivimab
    • Treatment
    • Ebolavirus
    • Palm
    • Virus
  • ebola
    • Virus
    • Infection
    • Outbreak
    • Drc
    • Drug
    • Zaire
    • Treatment
    • Rate
    • Three
    • Ebolavirus
    • Monoclonal
    • Odesivimab
  • zaire ebolavirus
    • Ebolavirus
    • Zaire
    • Inmazeb
    • Combination
    • Odesivimab
    • Treatment
    • Caused
    • Maftivimab
    • Atoltivimab
    • Monoclonal
    • Infection
    • Palm
  • atoltivimab
    • Maftivimab
    • Odesivimab
    • Ebolavirus
    • Monoclonal
    • Zaire
    • Treatment
    • Antibodies
    • Administration
    • Combination
    • Inmazeb
    • Caused
    • Three
  • maftivimab
    • Odesivimab
    • Ebolavirus
    • Monoclonal
    • Zaire
    • Treatment
    • Administration
    • Combination
    • Inmazeb
    • Caused
    • Three
    • Palm
    • Regn-eb3
  • 2018 équateur province ebola outbreak
    • Virus
    • Infection
    • Outbreak
    • Drc
    • Given
    • Drug
    • Zaire
    • Treatment
    • Patients
    • Rate
    • Three
    • Mab114

Connections between topic areas Semantic bridges

For Atoltivimab/maftivimab/odesivimab, one of the stronger structural bridges in this analysis connects Atoltivimab/maftivimab/odesivimab with History. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3
Atoltivimab/maftivimab/odesivimab — History · splits 20 ⟂ 17
Atoltivimab/maftivimab/odesivimab — Overview · splits 23 ⟂ 14
Atoltivimab/maftivimab/odesivimab — Pharmacology · splits 34 ⟂ 3

Map overview Semantic statistics

Atoltivimab/maftivimab/odesivimab

Nodes37
Edges36
Triples45
Avg. degree1.95
Density0.054054
Components1

Source & methodology

TTTA analyzes the structure around Atoltivimab/maftivimab/odesivimab to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Atoltivimab/maftivimab/odesivimab · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.

Monitor your Domain Rating with FrogDR

Featured onSUBMITATOR topicstotalkabout.com - Featured on Startup Fame Listed on Turbo0 Featured on Wired Business topicstotalkabout.com on Nick Launches Featured on neeed.directory Featured on PostYourStartup ShareSpeak on SaaSGrow Featured on DailyPings Startup Benchmarks Featured on EasyDoFollow Featured on EasyLaunch Featured on SubmitMySaas Featured on LaunchVault Featured on DodoDirectory Featured on LaunchZone Launched on LaunchBoard - Product Launch Platform Featured on LemonLaunch 'LiftOff' Default v2 badge Listed on CurlShip aListed onamaze.directory Featured on saas.fyi Featured on Brick Launch Featured on Wall of Tools Featured onfreeboard.lol #1 Product on Twelve ToolsFeatured onSUBMITATOR topicstotalkabout.com - Featured on Startup Fame Listed on Turbo0 Featured on Wired Business topicstotalkabout.com on Nick Launches Featured on neeed.directory Featured on PostYourStartup ShareSpeak on SaaSGrow Featured on DailyPings Startup Benchmarks Featured on EasyDoFollow Featured on EasyLaunch Featured on SubmitMySaas Featured on LaunchVault Featured on DodoDirectory Featured on LaunchZone Launched on LaunchBoard - Product Launch Platform Featured on LemonLaunch 'LiftOff' Default v2 badge Listed on CurlShip aListed onamaze.directory Featured on saas.fyi Featured on Brick Launch Featured on Wall of Tools Featured onfreeboard.lol #1 Product on Twelve Tools